|
US6074650A
(en)
|
1985-06-24 |
2000-06-13 |
Hoechst Aktiengesellschaft |
Membrane anchor/active compound conjugate, its preparation and its uses
|
|
AU5186090A
(en)
|
1989-02-23 |
1990-09-26 |
Colorado State University Research Foundation |
Gnrh analogs for destroying gonadotrophs
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US6106834A
(en)
|
1993-06-02 |
2000-08-22 |
Research Corporation Technologies, Inc. |
Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
|
|
US6024957A
(en)
|
1993-06-02 |
2000-02-15 |
Research Corporation Technologies, Inc. |
Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
|
|
GB9323199D0
(en)
|
1993-11-10 |
1994-01-05 |
Falkenberg J H F |
Leukaemia treatment
|
|
US6759509B1
(en)
|
1996-11-05 |
2004-07-06 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
WO2003048327A2
(en)
*
|
2001-12-03 |
2003-06-12 |
Abgenix, Inc. |
Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
|
|
TW200521231A
(en)
*
|
2003-09-18 |
2005-07-01 |
Novartis Ag |
Therapeutic binding molecules
|
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
EP1661584A1
(en)
|
2004-11-26 |
2006-05-31 |
Heinz Dr. Faulstich |
Use of conjugates of amatoxins and phallotoxins with macromolecules for cancer and inflammation therapy
|
|
US7947839B2
(en)
|
2004-12-01 |
2011-05-24 |
Genentech, Inc. |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
|
|
WO2007087453A2
(en)
|
2006-01-27 |
2007-08-02 |
Cellerant Therapeutics, Inc. |
Compositions and methods for treating haematological proliferative disorders
|
|
JP2009529522A
(ja)
|
2006-03-10 |
2009-08-20 |
ディアト |
酵素で切断可能なリンカーを介して抗体に複合された抗癌剤
|
|
ES2371085T3
(es)
|
2006-05-27 |
2011-12-27 |
Faulstich, Heinz, Dr. |
Utilización de conjugados de amatoxinas o falotoxinas con macromoléculas para la terapia tumoral y de la inflamación.
|
|
EP2032606B1
(en)
|
2006-05-30 |
2013-11-27 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
WO2008045976A2
(en)
*
|
2006-10-10 |
2008-04-17 |
Squicor |
Compositions and methods for treating and diagnosing cancers
|
|
WO2008067115A2
(en)
*
|
2006-11-03 |
2008-06-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Selective immunodepletion of endogenous stem cell niche for engraftment
|
|
PT2099823E
(pt)
|
2006-12-01 |
2014-12-22 |
Seattle Genetics Inc |
Agentes de ligação ao alvo variantes e suas utilizações
|
|
RU2583270C2
(ru)
*
|
2009-04-01 |
2016-05-10 |
Дженентек, Инк. |
АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
|
ES2784829T3
(es)
|
2009-04-08 |
2020-10-01 |
Faulstich Heinz Dr |
Componentes de unión a la superficie de células terapéuticas provistos de amatoxina diseñados para terapia de tumores
|
|
AU2010234335A1
(en)
|
2009-04-08 |
2011-10-13 |
Deutsches Krebsforschungszentrum |
Amatoxin-armed target-binding moieties for the treatment of cancer
|
|
CA2795349C
(en)
|
2010-04-15 |
2016-11-29 |
Seattle Genetics, Inc. |
Targeted pyrrolobenzodiazepine conjugates
|
|
ES2402254T3
(es)
|
2010-09-30 |
2013-04-30 |
Heidelberg Pharma Ag |
Conjugados de amatoxinas con ligadores mejorados
|
|
EP2497499A1
(en)
*
|
2011-03-10 |
2012-09-12 |
Heidelberg Pharma GmbH |
Amatoxin-conjugates with improved linkages
|
|
US9987308B2
(en)
*
|
2011-03-23 |
2018-06-05 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
MX393973B
(es)
|
2011-05-08 |
2025-03-24 |
Legochem Biosciences Inc |
Conjugados de proteína-agente activo y método para su preparación.
|
|
CN103997893B
(zh)
|
2011-10-14 |
2019-04-12 |
西雅图基因公司 |
吡咯并苯并二氮杂卓和靶向结合物
|
|
AU2012322932B2
(en)
|
2011-10-14 |
2016-11-10 |
Medimmune Limited |
Pyrrolobenzodiazepines
|
|
JP2015502397A
(ja)
|
2011-12-23 |
2015-01-22 |
ファイザー・インク |
部位特異的コンジュゲーションのための操作された抗体定常領域、ならびにそのための方法および使用
|
|
US9504756B2
(en)
|
2012-05-15 |
2016-11-29 |
Seattle Genetics, Inc. |
Self-stabilizing linker conjugates
|
|
EP2684865A1
(en)
|
2012-07-13 |
2014-01-15 |
Heidelberg Pharma GmbH |
Methods for synthesizing amatoxin building block and amatoxins
|
|
US20150218220A1
(en)
|
2012-09-12 |
2015-08-06 |
Brian Alan MENDELSOHN |
Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase
|
|
US9324898B2
(en)
*
|
2012-09-25 |
2016-04-26 |
Alliance For Sustainable Energy, Llc |
Varying cadmium telluride growth temperature during deposition to increase solar cell reliability
|
|
ES2732574T3
(es)
|
2012-11-30 |
2019-11-25 |
Novartis Ag |
Métodos para preparar conjugados a partir de proteínas que contienen disulfuro
|
|
KR102503695B1
(ko)
|
2013-02-28 |
2023-02-23 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
줄기세포를 동원하기 위한 방법 및 조성물
|
|
EP2774624A1
(en)
|
2013-03-04 |
2014-09-10 |
Heidelberg Pharma GmbH |
Amatoxin derivatives
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
EP2968591A1
(en)
*
|
2013-03-15 |
2016-01-20 |
Novartis AG |
Cell proliferation inhibitors and conjugates thereof
|
|
US9803002B2
(en)
|
2013-05-31 |
2017-10-31 |
Genentench, Inc. |
Anti-wall teichoic antibodies and conjugates
|
|
WO2014197854A1
(en)
|
2013-06-06 |
2014-12-11 |
Igenica Biotherapeutics, Inc. |
Novel linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
US10071170B2
(en)
|
2013-06-24 |
2018-09-11 |
Ablbio |
Antibody-drug conjugate having improved stability and use thereof
|
|
FR3008408B1
(fr)
|
2013-07-11 |
2018-03-09 |
Mc Saf |
Nouveaux conjugues anticorps-medicament et leur utilisation en therapie
|
|
CN105377304B
(zh)
*
|
2014-03-10 |
2018-05-15 |
海德堡医药有限责任公司 |
鹅膏毒肽衍生物
|
|
US9951141B2
(en)
|
2014-06-02 |
2018-04-24 |
Regeneron Pharmaceuticals, Inc. |
Antibody-drug conjugates, their preparation and their therapeutic use
|
|
US20170226209A1
(en)
*
|
2014-08-01 |
2017-08-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
An anti-cd45rc antibody for use as drug
|
|
RU2715905C2
(ru)
|
2014-10-01 |
2020-03-04 |
МЕДИММЬЮН, ЭлЭлСи |
Способ конъюгации полипептида
|
|
EP3209334A2
(en)
|
2014-10-20 |
2017-08-30 |
Igenica Biotherapeutics, Inc. |
Novel antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
EP3215519A1
(en)
|
2014-11-06 |
2017-09-13 |
Novartis AG |
Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
|
|
EP3026060A1
(en)
*
|
2014-11-26 |
2016-06-01 |
Miltenyi Biotec GmbH |
Humanized antibody or fragment thereof specific for CD45R0
|
|
US9729129B2
(en)
*
|
2014-12-05 |
2017-08-08 |
Bhaskar Gopalan |
System and method for reducing metastability in CMOS flip-flops
|
|
US20160220687A1
(en)
|
2015-02-02 |
2016-08-04 |
National Guard Health Affairs |
Metalloproteinase-cleavable alpha-amanitin-dendrimer conjugates and method of treating cancer
|
|
EP3268047B9
(en)
|
2015-03-09 |
2024-01-10 |
Heidelberg Pharma Research GmbH |
Amatoxin-antibody conjugates
|
|
HK1256681A1
(zh)
|
2015-04-06 |
2019-10-04 |
President And Fellows Of Harvard College |
用於非清髓性预处理的组合物和方法
|
|
EP3297684B1
(en)
|
2015-05-21 |
2020-12-23 |
Actinium Pharmaceuticals, Inc. |
Infusion administration of conjugated monoclonal antibodies
|
|
WO2017051249A1
(en)
|
2015-09-25 |
2017-03-30 |
Legochem Biosciences, Inc. |
Compositions and methods related to anti-cd19 antibody drug conjugates
|
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
|
MX378847B
(es)
|
2015-11-27 |
2025-03-11 |
Heidelberg Pharma Res Gmbh |
Nuevos derivados de gamma-amanitina
|
|
EP3222292A1
(en)
|
2016-03-03 |
2017-09-27 |
Heidelberg Pharma GmbH |
Amanitin conjugates
|
|
WO2017155937A1
(en)
|
2016-03-07 |
2017-09-14 |
Actinium Pharmaceuticals, Inc. |
Stabilized radiolabeled anti-cd45 immunoglobulin compositions
|
|
BR112018071465A2
(pt)
|
2016-04-20 |
2019-02-05 |
Hangzhou Dac Biotech Co Ltd |
derivados de toxinas de amanita e sua conjugação a uma molécula de ligação celular
|
|
WO2017191579A1
(en)
|
2016-05-05 |
2017-11-09 |
Novartis Ag |
Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
|
|
JP6738909B2
(ja)
|
2016-05-27 |
2020-08-12 |
アクティニウム ファーマシューティカルズ インコーポレイテッド |
血液悪性疾患を処置するための低用量抗体に基づく方法
|
|
WO2017210288A1
(en)
|
2016-05-31 |
2017-12-07 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates having derivatives of amatoxin as the drug
|
|
IL263744B2
(en)
|
2016-06-17 |
2023-11-01 |
Magenta Therapeutics Inc |
Compositions and methods for the depletion of cd117 plus cells
|
|
EP3500663A1
(en)
|
2016-08-29 |
2019-06-26 |
PDI Pharm Development International AG |
Provision of a therapeutically active cell product
|
|
US10112266B2
(en)
*
|
2016-09-09 |
2018-10-30 |
Baltic Innovation Holding PRO, AS |
Pressed thermite rod for a self-contained portable cutting device
|
|
WO2018071871A1
(en)
*
|
2016-10-13 |
2018-04-19 |
President And Fellows Of Harvard College |
Compositions and methods for non-myeloablative conditioning
|
|
RU2755728C2
(ru)
|
2016-12-23 |
2021-09-20 |
Хайдельберг Фарма Ресёрч Гмбх |
Новый конъюгат аманитина
|
|
EP3571230A4
(en)
|
2017-01-20 |
2020-12-16 |
Magenta Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR DELETION OF CD137 + CELLS
|
|
KR20190109440A
(ko)
|
2017-01-30 |
2019-09-25 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
줄기 세포 이식을 위한 비-유전독성 컨디셔닝 레지멘
|
|
CN110997676B
(zh)
|
2017-08-07 |
2022-12-20 |
海德堡医药研究有限责任公司 |
合成鹅膏蕈碱的新方法
|